Patents by Inventor Yu Bai

Yu Bai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250140129
    Abstract: The present application relates to a model for training a high-simulation colonoscopy, and relates to the field of a medical training model. The model includes a colon model and a polypus model detachably mounted on the colon model. The colon model is opened and provided with polypus replacing points for mounting the polypus model. The polypus replacing points are provided on different intestinal segments of the colon model. The polypus replacing points are provided at a plurality of different positions in a circumferential direction of the colon model. This application has the effect of simulating a variety of polypus lesion training scenarios, which contributes to the efficient conduct of colonoscopy training.
    Type: Application
    Filed: October 31, 2023
    Publication date: May 1, 2025
    Applicants: The First Affiliated Hospital of Naval Medical University, Preclinic Medtech (Shanghai) Co., Ltd.
    Inventors: Shengbing Zhao, Chenglong Wang, Yu Bai, Xiangyu Sui, Song Zhang, Changhao Peng, Wanzhong Wu
  • Patent number: 12261297
    Abstract: The present invention discloses a pre-lithiated silicon-carbon multilayer composite negative electrode material for lithium ion batteries and a preparation method thereof. The composite negative electrode material includes an amorphous carbon matrix, pre-lithiated silicon monoxide particles and graphene materials; the graphene materials are uniformly coated on the outer surface of the pre-lithiated silicon monoxide to form composite particles; and the composite particles are uniformly dispersed in the amorphous carbon matrix. According to the present invention, the silicon monoxide particles are pre-lithiated to greatly improve the initial coulombic efficiency (ICE) of the silicon-based negative electrode material; the graphene materials greatly improve the mechanical performance and conductivity of the composite materials due to the light weight, high strength and excellent conductivity thereof.
    Type: Grant
    Filed: March 22, 2022
    Date of Patent: March 25, 2025
    Assignee: FUJIAN XFH NEW ENERGY MATERIALS CO., LTD.
    Inventors: Donghui Zhao, Pengwei Zhou, Yu Bai
  • Publication number: 20250068901
    Abstract: Embodiments described herein provide a diffusion-based framework that is trained on a dataset with limited text labels, to generate a distribution of data samples in the dataset given a specific text description label. Specifically, firstly, unlabeled data is used to train the diffusion model to generate a data distribution of data samples given a specific text description label. Then text-labeled data samples are used to finetune the diffusion model to generate data distribution given a specific text description label, thus enhancing controllability of training.
    Type: Application
    Filed: January 25, 2024
    Publication date: February 27, 2025
    Inventors: Shiyu Wang, Yihao Feng, Tian Lan, Ning Yu, Yu Bai, Ran Xu, Huan Wang, Caiming Xiong, Silvio Savarese
  • Publication number: 20250025067
    Abstract: Systems and methods for motor assessment including receiving first sensed signals in response to a first motor assessment performed using a first test device, receiving second sensed signals in response to a second motor assessment different than the first motor assessment and performed using the first test device, performing noise reduction for the first sensed signals and the second sensed signals, performing position normalization for the first sensed signals and the second sensed signals, generating transformed signals based on the noise reduction and the position normalization for the first sensed signals and the second sensed signals, extracting features based on the transformed signals, providing the extracted features to a machine learning model trained to output a motor assessment based prediction based on the transformed signals; and/or receiving the motor assessment based prediction from the machine learning model.
    Type: Application
    Filed: July 19, 2024
    Publication date: January 23, 2025
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Shawn Luke MISHRA, Bharatkumar KOYANI, Matthew F. WIPPERMAN, Oren LEVY, Yu BAI
  • Patent number: 12187725
    Abstract: The present application provides tricyclic urea compounds that modulate the activity of the V617F variant of JAK2, which are useful in the treatment of various diseases, including cancer.
    Type: Grant
    Filed: August 24, 2023
    Date of Patent: January 7, 2025
    Assignee: Incyte Corporation
    Inventors: Yanran Ai, Yu Bai, Joseph Barbosa, Hao Feng, Leah C. Konkol, Xun Liu, Jun Pan, Haisheng Wang, Liangxing Wu, Wenqing Yao, Eddy W. Yue
  • Patent number: 12070160
    Abstract: An individual serving size food dispenser includes a casing defining an interior volume configured for receipt of bulk food. An opening of the casing is positioned proximate a bottom portion of the interior volume. An auger is disposed within the interior volume of the casing. The auger includes a first flighting portion and a second flighting portion. The first and second flighting portions are wound in opposite directions. An auger motor is coupled to the auger such that the auger motor is operable to rotate the auger within the interior volume of the casing. A door assembly is positioned proximate the opening of the casing. The door assembly is configured for selectively opening to dispense bulk food from the opening of the casing.
    Type: Grant
    Filed: January 19, 2023
    Date of Patent: August 27, 2024
    Assignee: GOOGLE LLC
    Inventors: James Edward Shaw, Gerald Reid Harris, Ignacio Alfonzo Mendez, Yu Bai, Dennis Franklin Olson, Roger Nihl Re
  • Patent number: 12041918
    Abstract: Methods and compositions are provided for generating F0 fertile XY female animals. The methods and compositions involve making XY pluripotent or totipotent animal cells, in vitro cell cultures, or embryos that are capable of producing a fertile female XY animal in an F0 generation. Such cells, embryos, and animals can be made by silencing a region of the Y chromosome. Optionally, the cells can also be cultured in feminizing medium such as a low-osmolality medium and/or can be modified to decrease the level and/or activity of an Sry protein. Methods and compositions are also provided for silencing a region of the Y chromosome in an XY pluripotent or totipotent animal cell, or in vitro cell cultures, embryos, or animals derived therefrom, by maintaining an XY pluripotent or totipotent animal cell in a feminizing medium.
    Type: Grant
    Filed: December 11, 2020
    Date of Patent: July 23, 2024
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Jennifer Schmahl, David Frendewey, Junko Kuno, Chia-Jen Siao, Gustavo Droguett, Yu Bai, Wojtek Auerbach
  • Publication number: 20240241344
    Abstract: An imaging lens including a first lens group, a second lens group, and an aperture stop disposed between the first lens group and the second lens group is provided. The first lens group includes at least one and at most three lenses with refractive powers, and the second lens group has a positive refractive power and includes at least two and at most three lenses with a refractive powers. The imaging lens satisfies conditions of 2 mm<LT<20 mm and 0.8<D1/LT<1.4, where D1 is a lens diameter of the lens closest to the object side, and LT is distance along the optical axis between two outermost lens surfaces at opposite ends of the first lens group and the second lens group.
    Type: Application
    Filed: April 4, 2023
    Publication date: July 18, 2024
    Inventors: HAN-TING HUANG, CHI-YU BAI, CHING-LUNG LAI
  • Publication number: 20240182887
    Abstract: Methods and systems for CRISPR positive selection are described. CRISPR positive selection uses DNA sequencing to identify genes that their perturbation by CRISPR guide RNAs is correlated to the phenotype. In some aspects, disclosed are genome-wide CRISPR/Cas9 screening methods to identify genetic modifiers. Also disclosed are the apparatuses used for performing the methods.
    Type: Application
    Filed: November 7, 2023
    Publication date: June 6, 2024
    Inventors: Wen Fury, Yu Bai
  • Publication number: 20240150354
    Abstract: The present application provides tricyclic urea compounds that modulate the activity of the V617F variant of JAK2, which are useful in the treatment of various diseases, including cancer.
    Type: Application
    Filed: August 24, 2023
    Publication date: May 9, 2024
    Inventors: Yanran Ai, Onur Atasoylu, Yu Bai, Joseph Barbosa, David M. Burns, Daniel Levy, Brent Douty, Hao Feng, Leah C. Konkol, Cheng-Tsung Lai, Xun Liu, Song Mei, Jun Pan, Haisheng Wang, Liangxing Wu, Wenqing Yao, Eddy W. Yue
  • Publication number: 20240144482
    Abstract: Technologies are provided for alignment of spatial transcriptome slides of biological tissue. The alignment of images and the coordinates of spots within transcriptome profiles of the biological tissue can utilize an alignment model that can be machine-learned and can receive both a displaced image to be aligned and a reference image as inputs. The alignment model may learn a diffeomorphic transformation between those images. Such a transformation can be readily applied to the alignment of the displaced image and to the alignment of the displaced coordinates of spots within the transcriptome profiles of transcriptome. In some cases, transcriptome data can be analyzed and cast in an image-like format, and can then be utilized as supplementary input to the alignment model. The alignment model can be trained in a tissue agnostic manner, such as by using synthetic images.
    Type: Application
    Filed: November 1, 2023
    Publication date: May 2, 2024
    Inventors: Peter Lais, Shawn Mishra, Yu Bai, Gurinder S. Atwal
  • Publication number: 20240083918
    Abstract: Disclosed are compounds of Formula (I), methods of using the compounds for inhibiting ALK2 activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associated with ALK2 activity such as cancer.
    Type: Application
    Filed: October 31, 2023
    Publication date: March 14, 2024
    Inventors: Jun Pan, Yu Bai, Liangxing Wu, Wenqing Yao
  • Patent number: 11912768
    Abstract: The present invention relates to the field of medical biology, and discloses a single domain antibody and derivative proteins thereof against CTLA4. In particular, the present invention discloses a CTLA4 binding protein and the use thereof, especially the use for treating and/or preventing CTLA4 relevant diseases such as tumor.
    Type: Grant
    Filed: July 7, 2021
    Date of Patent: February 27, 2024
    Assignees: SUZHOU ALPHAMAB CO., LTD., XITIAN ZHANG, XIN ZHANG
    Inventors: Ting Xu, Xiaoxiao Wang, Jie Li, Haiyan Wu, Li Gao, Qian Chu, Yu Bai
  • Patent number: 11876724
    Abstract: The technology of this application relates to a flow characteristic extraction method and apparatus, and belongs to the field of network technologies. The method includes a network device that determines a burst parameter of a burst traffic segment of a received first packet flow, and determines a burst parameter of the first packet flow based on the burst parameter of the burst traffic segment of the first packet flow. The first packet flow is an elephant flow, the burst traffic segment indicates a burst degree of traffic within one period of time, the burst parameter of the burst traffic segment is a parameter used to describe the burst traffic segment, and the burst parameter of the first packet flow is a parameter used to describe at least one burst traffic segment included in the first packet flow.
    Type: Grant
    Filed: August 29, 2022
    Date of Patent: January 16, 2024
    Assignee: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Zhen Wang, Wenbin Yang, Yu Bai, Guang Li
  • Publication number: 20230416728
    Abstract: Cas-protein-ready tau biosensor cells, CRISPR/Cas synergistic activation mediator (SAM)-ready tau biosensor cells, and methods of making and using such cells to screen for genetic vulnerability associated with tau aggregation are provided.
    Type: Application
    Filed: August 31, 2023
    Publication date: December 28, 2023
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Marine Prissette, Matthew Koss, Yu Bai, Brian Zambrowicz
  • Publication number: 20230409478
    Abstract: Latency on the miss path to a cache level in a CPU module is reduced by predicting when a cache miss is likely. Main memory is directly accessed in parallel with the access to the cache level in the CPU module based on the prediction that a cache miss is likely in the cache level.
    Type: Application
    Filed: September 1, 2023
    Publication date: December 21, 2023
    Inventors: Kermin CHOFLEMING, Yu BAI, Simon C. STEELY, JR.
  • Patent number: 11845930
    Abstract: Methods and systems for CRISPR positive selection are described. CRISPR positive selection uses DNA sequencing to identify genes that their perturbation by CRISPR guide RNAs is correlated to the phenotype. In some aspects, disclosed are genome-wide CRISPR/Cas9 screening methods to identify genetic modifiers. Also disclosed are the apparatuses used for performing the methods.
    Type: Grant
    Filed: March 17, 2020
    Date of Patent: December 19, 2023
    Assignee: Regeneron Pharmaceuticals Inc.
    Inventors: Wen Fury, Yu Bai
  • Patent number: 11840546
    Abstract: Disclosed are compounds of Formula (I), methods of using the compounds for inhibiting ALK2 activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associated with ALK2 activity such as cancer.
    Type: Grant
    Filed: June 10, 2021
    Date of Patent: December 12, 2023
    Assignee: Incyte Corporation
    Inventors: Jun Pan, Yu Bai, Liangxing Wu, Wenqing Yao
  • Publication number: 20230334245
    Abstract: Embodiments described herein provide a Conformal Predictor (CP) that reduces the number of likely target class labels CP. Specifically, the CP provides a model agnostic framework to generate a label set, instead of a single label prediction, within a pre-defined error rate. The CP employs a fast base classifier which may be used to filter out unlikely labels from the target label set, and thus restrict the number of probable target class labels while ensuring the candidate class labels set meets the pre-defined error rate.
    Type: Application
    Filed: August 16, 2022
    Publication date: October 19, 2023
    Inventors: Prafulla Kumar Choubey, Yu Bai, Nazneen Rajani, Wenhao Liu
  • Patent number: D1066904
    Type: Grant
    Filed: February 24, 2022
    Date of Patent: March 18, 2025
    Assignee: GOOGLE LLC
    Inventors: Yu Bai, Nick Gillett